Morning Headlines 8/2/16

Theranos Founder Elizabeth Holmes Introduces New Blood-Testing Device

During a speech at the annual meeting of the American Association for Clinical Chemistry, Theranos CEO Elizabeth Holmes announces that her lab test startup has invented a new analyzer that uses small amounts of blood and performs more tests than the company’s Edison analyzer.

Struggling To Stabilize: 3Rs Litigation And The Future Of The ACA Exchanges

Health Affairs recaps the numerous lawsuits being brought against the federal government by insurers and co-ops struggling to maintain profitability on the ACA marketplaces.

Identification of 15 genetic loci associated with risk of major depression in individuals of European descent

Researchers using 23andMe’s genome database to look for genetic variants associated with major depressive disorder find 15 previously unknown mutations that correlated with an increased risk of depression.

CMS selects markets for new primary-care payment initiative

CMS will launch the Comprehensive Primary Care Plus program in 14 regions, including  Arkansas, Colorado, Hawaii, Kansas City (MO) Michigan, Montana, New Jersey, North Hudson Valley (NY), Oklahoma, Oregon, Rhode Island, Tennessee and parts of Ohio and Kentucky.